These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. MicroRNAs in kidney physiology and disease. Trionfini P; Benigni A; Remuzzi G Nat Rev Nephrol; 2015 Jan; 11(1):23-33. PubMed ID: 25385286 [TBL] [Abstract][Full Text] [Related]
25. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment. Elliott HL Blood Press Suppl; 1994; 2():31-4. PubMed ID: 8061843 [TBL] [Abstract][Full Text] [Related]
26. Progression of chronic renal disease and diabetic nephropathy: a review of clinical studies and current therapy. Marinides GN J Med; 1993; 24(4-5):266-88. PubMed ID: 8258740 [TBL] [Abstract][Full Text] [Related]
27. Options in uraemia therapy for diabetics with end-stage renal disease. Polenaković MH Prilozi; 2004; 25(1-2):27-51. PubMed ID: 15735534 [TBL] [Abstract][Full Text] [Related]
28. How will gene therapy apply to the kidney in the 21st century? Kone BC Semin Nephrol; 2000 Jan; 20(1):47-59. PubMed ID: 10651218 [TBL] [Abstract][Full Text] [Related]
30. Role of endothelin and endothelin receptor antagonists in renal disease. Neuhofer W; Pittrow D Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy for renal diseases. Lien YH; Lai LW Kidney Int Suppl; 1997 Oct; 61():S85-8. PubMed ID: 9328975 [TBL] [Abstract][Full Text] [Related]
32. Report from the Caribbean renal registry, 2006. Soyibo AK; Barton EN West Indian Med J; 2007 Sep; 56(4):355-63. PubMed ID: 18198742 [TBL] [Abstract][Full Text] [Related]
34. Diabetic nephropathy: early detection, prevention and management. Maher JF Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042 [TBL] [Abstract][Full Text] [Related]
35. Management of acute renal failure in the elderly. Treatment options. Mandal AK; Baig M; Koutoubi Z Drugs Aging; 1996 Oct; 9(4):226-50. PubMed ID: 8894522 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond. Nassirpour R; Raj D; Townsend R; Argyropoulos C Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770 [TBL] [Abstract][Full Text] [Related]
37. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis? Wyne KL; Fishbane S; Block GA; Warburton K; Berns JS; Neu AM; Warady BA Semin Dial; 2006; 19(1):8-24. PubMed ID: 16423174 [No Abstract] [Full Text] [Related]
38. Gene therapy in renal diseases. Imai E; Takabatake Y; Mizui M; Isaka Y Kidney Int; 2004 May; 65(5):1551-5. PubMed ID: 15086890 [TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of preemptive kidney transplantation in patients with diabetes mellitus. Son YK; Oh JS; Kim SM; Jeon JM; Shin YH; Kim JK Transplant Proc; 2010 Nov; 42(9):3497-502. PubMed ID: 21094803 [TBL] [Abstract][Full Text] [Related]
40. Renal diseases as targets of gene therapy. Phillips B; Giannoukakis N; Trucco M Contrib Nephrol; 2008; 159():1-12. PubMed ID: 18391581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]